Abstract
Curcumin is a small organic molecule with pleiotropic biological activities. However, its multiple structural-pharmacokinetic challenges prevent its development into a clinical drug. Various structural modifications have been made to improve its drug profile. In this review, we focus on the methods adopted in the synthesis of asymmetric curcumin derivatives and their biological activities and forecast the future of this exciting class of compounds in the field of medicine.
Keywords:
Asymmetric curcumin; Bioactivity; Diketone; Monoketone; Synthesis.
Copyright © 2019 Elsevier Masson SAS. All rights reserved.
MeSH terms
-
Acute Lung Injury / drug therapy
-
Animals
-
Anti-Inflammatory Agents, Non-Steroidal / chemical synthesis
-
Anti-Inflammatory Agents, Non-Steroidal / chemistry
-
Anti-Inflammatory Agents, Non-Steroidal / pharmacology*
-
Antineoplastic Agents / chemical synthesis
-
Antineoplastic Agents / chemistry
-
Antineoplastic Agents / pharmacology*
-
Carbonic Anhydrase Inhibitors / chemical synthesis
-
Carbonic Anhydrase Inhibitors / chemistry
-
Carbonic Anhydrase Inhibitors / pharmacology*
-
Carbonic Anhydrases / metabolism
-
Curcumin / chemical synthesis
-
Curcumin / chemistry
-
Curcumin / pharmacology*
-
Humans
-
Molecular Structure
-
Neoplasms / drug therapy*
Substances
-
Anti-Inflammatory Agents, Non-Steroidal
-
Antineoplastic Agents
-
Carbonic Anhydrase Inhibitors
-
Carbonic Anhydrases
-
Curcumin